AKT1 and lung carcinoma: For example, RVT has been shown to reverse tumor chemoresistance in lung cancer by inhibiting the PI3K/AKT/mTOR pathway, thereby enhancing cisplatin sensitivity—mechanistically consistent with our observations regarding β-elemene.